Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Interest & Investment Income (2023 - 2025)

Health Catalyst (HCAT) has disclosed Interest & Investment Income for 3 consecutive years, with -$4.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 209.05% year-over-year to -$4.7 million, compared with a TTM value of -$14.4 million through Sep 2025, down 347.99%, and an annual FY2024 reading of $637000.0, down 93.0% over the prior year.
  • Interest & Investment Income was -$4.7 million for Q3 2025 at Health Catalyst, down from -$3.8 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.6 million in Q4 2023 and bottomed at -$4.7 million in Q3 2025.
  • Average Interest & Investment Income over 3 years is -$190454.5, with a median of $1.8 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income surged 30.4% in 2024, then crashed 261.08% in 2025.
  • Year by year, Interest & Investment Income stood at $2.6 million in 2023, then plummeted by 197.4% to -$2.5 million in 2024, then plummeted by 83.63% to -$4.7 million in 2025.
  • Business Quant data shows Interest & Investment Income for HCAT at -$4.7 million in Q3 2025, -$3.8 million in Q2 2025, and -$3.4 million in Q1 2025.